Company Filing History:
Years Active: 2020-2023
Title: Innovations in HIV Vaccine Development by Inventor Natalia De Val
Introduction
Natalia De Val is an innovative inventor based in San Diego, CA, who has made significant contributions to the field of HIV vaccine development. With three patents to her name, she is recognized for her pioneering work that aims to enhance the efficacy of vaccines against HIV.
Latest Patents
De Val’s latest patents focus on breakthrough HIV-1 vaccine immunogens. One of her notable inventions involves HIV-1 GP140 immunogens that comprise modified NHR1 regions, which play a crucial role in stabilizing pre-fusion envelope conformations. This ground-breaking approach utilizes soluble gp140-derived proteins and HIV-1 Env-derived trimer proteins presented on a nanoparticle platform. The methods she developed aim to elicit a robust immune response, contributing to the potential treatment of HIV infections.
Another important patent by De Val pertains to nucleic acids encoding HIV-1 GP140 immunogens with modified NHR1 regions. Similar to her other invention, it utilizes innovative techniques to stabilize pre-fusion conformations of the virus, further advancing the understanding and development of effective vaccines.
Career Highlights
Natalia De Val works at The Scripps Research Institute, where she collaborates with leading scientists in the field. Her research has culminated in multiple patents that not only address the complexities of HIV but also highlight her commitment to finding solutions for global health challenges.
Collaborations
Throughout her career, De Val has worked closely with notable coworkers including Leopold Kong and Ian A. Wilson. These collaborations exemplify the spirit of teamwork in scientific research, pushing the boundaries of what is possible in medical advancements.
Conclusion
With a strong portfolio of patents and significant contributions to the HIV vaccine landscape, Natalia De Val stands as a prominent figure in biomedicine. Her innovative approach and collaborative efforts inspire future research in the field, aiming towards a future where HIV infections can be effectively managed or even eradicated.